Right to health and technology assessment in courts: an empirical analysis (360G-Wellcome-200120_Z_15_Z)

£10,000

Judicial claims for the provision of high-cost drugs funded by the public health system have been growing in Brazil, as has the economic costs on the government’s budget of complying with the court orders. Claimants’ rate of success is high as courts tend to accept that treatments must be publicly funded whenever they can offer any health benefit to an individual patient, ignoring cost considerations and relying on weak scientific evidence. In 2011 a new body – CONITEC – was established to make decisions on the incorporation of healthtechnologies in the public health system more transparent, accountable and scientifically rigorous. Our hypothesis is that judicial claims will be significantly less successful if the claimed treatment was assessed by CONITEC and, based on the assessment, there was a decision not to publicly fund it. To test thishypothesis we will compare patients’ rate of success in claims for treatments assessed by CONITEC before and after the assessment, and in claims for these treatments as opposed to those for other non-assessed treatments during the same period.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 10000
Applicant Surname Wang
Approval Committee Internal Prelim Decision Panel
Award Date 2015-11-30T00:00:00+00:00
Financial Year 2015/16
Grant Programme: Title Small grant in H&SS
Internal ID 200120/Z/15/Z
Lead Applicant Dr Daniel Wang
Partnership Value 10000
Planned Dates: End Date 2018-04-11T00:00:00+00:00
Planned Dates: Start Date 2016-04-12T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London